Paul Hastings Advised Raymond James in U.K.-Based Zura Bio Limited’s Cross-Border Business Combination with JATT Acquisition Corp
March 23, 2023
Paul Hastings LLP advised Raymond James as financial advisor in connection with U.K. clinical-stage biotechnology company Zura Bio Limited’s de-SPAC merger with JATT Acquisition Corp. As a result of the merger, the combined company’s shares are trading on Nasdaq under the ticker “ZURA.”
This successful listing by a U.K. company on Nasdaq demonstrates the continued success of Paul Hastings’ cross-border capital markets offering.
About Paul Hastings
With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment and real estate, Paul Hastings is a premier law firm providing superior intellectual capital and execution globally to the world’s leading investment banks, asset managers and corporations.